Cannabis - Aspectos regulatorios: Impacto de las medidas

Cambios en la prevalencia de consumo

• Fuente: PubMed [Internet]. Bethesda (MD): US National Library of Medicine National Institutes of Health; [consulta 25 mayo 2022]. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/
• Detalles de búsqueda: ((("cannabis"[MeSH Terms] OR "cannabis"[All Fields]) AND ("legal"[All Fields] OR "legalism"[All Fields] OR "legalities"[All Fields] OR "legality"[All Fields] OR "legalization"[All Fields] OR "legalize"[All Fields] OR "legalized"[All Fields] OR "legalizes"[All Fields] OR "legalizing"[All Fields] OR "legally"[All Fields]) AND ("epidemiology"[MeSH Subheading] OR "epidemiology"[All Fields] OR "prevalence"[All Fields] OR "prevalence"[MeSH Terms]) AND "humans"[MeSH Terms]) AND (("cannabis"[MeSH Terms] OR "cannabis"[All Fields]) AND ("legal"[All Fields] OR "legalism"[All Fields] OR "legalities"[All Fields] OR "legality"[All Fields] OR "legalization"[All Fields] OR "legalize"[All Fields] OR "legalized"[All Fields] OR "legalizes"[All Fields] OR "legalizing"[All Fields] OR "legally"[All Fields]) AND ("epidemiology"[MeSH Subheading] OR "epidemiology"[All Fields] OR "prevalence"[All Fields] OR "prevalence"[MeSH Terms])) AND "humans"[MeSH Terms]) AND ((y_5[Filter]) AND (meta-analysis[Filter] OR review[Filter] OR systematicreview[Filter]))

NOTA – Debido al altísimo nº de los resultados obtenido, las Novedades de los años 2019-2022 son entradas formadas por revisiones, revisiones sistemáticas y metaánalisis.

2022

• Wadsworth E, Craft S, Calder R, Hammond D. Prevalence and use of cannabis products and routes of administration among youth and young adults in Canada and the United States: A systematic review. Addict Behav. junio de 2022;129:107258.
• Gunn RL, Aston ER, Metrik J. Patterns of Cannabis and Alcohol Co-Use: Substitution Versus Complementary Effects. Alcohol Res. 2022;42(1):04.
• Brenneke SG, Nordeck CD, Riehm KE, Schmid I, Tormohlen KN, Smail EJ, Johnson RM, Kalb LG, Stuart EA, Thrul J. Trends in cannabis use among U.S. adults amid the COVID-19 pandemic. Int J Drug Policy. 2022 Feb;100:103517.
• Weinberger AH, Wyka K, Kim JH, Smart R, Mangold M, Schanzer E, et al. A difference-in-difference approach to examining the impact of cannabis legalization on disparities in the use of cigarettes and cannabis in the United States, 2004-17. Addiction. 5 de enero de 2022;
• Fischer B, Robinson T, Bullen C, Curran V, Jutras-Aswad D, Medina-Mora ME, et al. Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations update. Int J Drug Policy. enero de 2022;99:103381.

2021

• Vignault C, Massé A, Gouron D, Quintin J, Asli KD, Semaan W. The Potential Impact of Recreational Cannabis Legalization on the Prevalence of Cannabis Use Disorder and Psychotic Disorders: A Retrospective Observational Study. Can J Psychiatry. diciembre de 2021;66(12):1069-76.
• Wong CF, Mendez SEA, Conn BM, Iverson E, Lankenau SE. Attitudes and beliefs about recreational cannabis legalization among cannabis-using young adults in Los Angeles: Impact on concurrent cannabis practices and problematic cannabis use. Drug Alcohol Depend. 1 de noviembre de 2021;228:109053.
• Doucette ML, Borrup KT, Lapidus G, Whitehill JM, McCourt AD, Crifasi CK. Effect of Washington State and Colorado’s cannabis legalization on death by suicides. Prev Med. julio de 2021;148:106548.
• Athanassiou M, Dumais A, Gnanhoue G, Abdel-Baki A, Jutras-Aswad D, Potvin S. A systematic review of longitudinal studies investigating the impact of cannabis use in patients with psychotic disorders. Expert Rev Neurother. julio de 2021;21(7):779-91.
• Rosic T, Sanger N, Panesar B, Foster G, Marsh DC, Rieb L, et al. Cannabis use in patients treated for opioid use disorder pre- and post-recreational cannabis legalization in Canada. Subst Abuse Treat Prev Policy. 13 de abril de 2021;16(1):34.
• Scheier LM, Griffin KW. Youth marijuana use: a review of causes and consequences. Curr Opin Psychol. abril de 2021;38:11-8.
• Hasin D, Walsh C. Trends over time in adult cannabis use: A review of recent findings. Curr Opin Psychol. abril de 2021;38:80-5.
• Nemer L, Lara LF, Hinton A, Conwell DL, Krishna SG, Balasubramanian G. Impact of Recreational Cannabis Legalization on Hospitalizations for Hyperemesis. Am J Gastroenterol. 1 de marzo de 2021;116(3):609-12.
• Connor JP, Stjepanović D, Le Foll B, Hoch E, Budney AJ, Hall WD. Cannabis use and cannabis use disorder. Nat Rev Dis Primers. 25 de febrero de 2021;7(1):16.
• Kim JH, Weinberger AH, Zhu J, Barrington-Trimis J, Wyka K, Goodwin RD. Impact of state-level cannabis legalization on poly use of alcohol and cannabis in the United States, 2004-2017. Drug Alcohol Depend. 1 de enero de 2021;218:108364.

2020

• Scheim AI, Maghsoudi N, Marshall Z, Churchill S, Ziegler C, Werb D. Impact evaluations of drug decriminalisation and legal regulation on drug use, health and social harms: a systematic review. BMJ Open. 21 de septiembre de 2020;10(9):e035148.
• Steigerwald S, Cohen BE, Vali M, Hasin D, Cerdà M, Keyhani S. Differences in Opinions About Marijuana Use and Prevalence of Use by State Legalization Status. J Addict Med. agosto de 2020;14(4):337-44.
• Dellazizzo L, Potvin S, Dou BY, Beaudoin M, Luigi M, Giguère C-É, et al. Association Between the Use of Cannabis and Physical Violence in Youths: A Meta-Analytical Investigation. Am J Psychiatry. 1 de julio de 2020;177(7):619-26.
• Laqueur H, Rivera-Aguirre A, Shev A, Castillo-Carniglia A, Rudolph KE, Ramirez J, et al. The impact of cannabis legalization in Uruguay on adolescent cannabis use. Int J Drug Policy. junio de 2020;80:102748.
• Hammond CJ, Chaney A, Hendrickson B, Sharma P. Cannabis use among U.S. adolescents in the era of marijuana legalization: a review of changing use patterns, comorbidity, and health correlates. Int Rev Psychiatry. mayo de 2020;32(3):221-34.
• Docter S, Khan M, Gohal C, Ravi B, Bhandari M, Gandhi R, et al. Cannabis Use and Sport: A Systematic Review. Sports Health. abril de 2020;12(2):189-99.
• Winters KC, Whelan JP. Gambling and Cannabis Use: Clinical and Policy Implications. J Gambl Stud. marzo de 2020;36(1):223-41.
• Karoly HC, Ross JM, Ellingson JM, Feldstein Ewing SW. Exploring Cannabis and Alcohol Co-Use in Adolescents: A Narrative Review of the Evidence. J Dual Diagn. marzo de 2020;16(1):58-74.
• Grigsby TM, Hoffmann LM, Moss MJ. Marijuana Use and Potential Implications of Marijuana Legalization. Pediatr Rev. febrero de 2020;41(2):61-72.
• Greaves L, Hemsing N. Sex and Gender Interactions on the Use and Impact of Recreational Cannabis. Int J Environ Res Public Health. 14 de enero de 2020;17(2):E509.
• Santaella-Tenorio J, Wheeler-Martin K, DiMaggio CJ, Castillo-Carniglia A, Keyes KM, Hasin D, Cerdà M. Association of Recreational Cannabis Laws in Colorado and Washington State With Changes in Traffic Fatalities, 2005-2017. JAMA Intern Med. 1 de agosto de 2020;180(8):1061-8.
• Wright A, Cather C, Gilman J, Evins AE. The Changing Legal Landscape of Cannabis Use and Its Role in Youth-onset Psychosis. Child Adolesc Psychiatr Clin N Am. enero de 2020;29(1):145-56.
• Veligati S, Howdeshell S, Beeler-Stinn S, Lingam D, Allen PC, Chen L-S, et al. Changes in alcohol and cigarette consumption in response to medical and recreational cannabis legalization: Evidence from U.S. state tax receipt data. Int J Drug Policy. enero de 2020;75:102585.

2019

• Fischer B, Russell C, Rehm J, Leece P. Assessing the public health impact of cannabis legalization in Canada: core outcome indicators towards an «index» for monitoring and evaluation. J Public Health (Oxf). 1 de junio de 2019;41(2):412-21.
• Hosseini S, Oremus M. The Effect of Age of Initiation of Cannabis Use on Psychosis, Depression, and Anxiety among Youth under 25 Years. Can J Psychiatry. mayo de 2019;64(5):304-12.
• Budney AJ, Sofis MJ, Borodovsky JT. An update on cannabis use disorder with comment on the impact of policy related to therapeutic and recreational cannabis use. Eur Arch Psychiatry Clin Neurosci. febrero de 2019;269(1):73-86.
• Smart R, Pacula RL. Early evidence of the impact of cannabis legalization on cannabis use, cannabis use disorder, and the use of other substances: Findings from state policy evaluations. Am J Drug Alcohol Abuse. 2019;45(6):644-63.
• Manolis TA, Manolis AA, Manolis AS. Cannabis Associated «High» Cardiovascular Morbidity and Mortality: Marijuana Smoke Like Tobacco Smoke? A Déjà Vu/Déjà Vécu Story? Mini Rev Med Chem. 2019;19(11):870-9.
• Hasin DS, Shmulewitz D, Sarvet AL. Time trends in US cannabis use and cannabis use disorders overall and by sociodemographic subgroups: a narrative review and new findings. Am J Drug Alcohol Abuse. 2019;45(6):623-43.
• Mahamad S, Hammond D. Retail price and availability of illicit cannabis in Canada. Addict Behav. marzo de 2019;90:402-8.
• Reddon H, Fast D, DeBeck K, Werb D, Hayashi K, Wood E, et al. Prevalence and correlates of selling illicit cannabis among people who use drugs in Vancouver, Canada: A ten-year prospective cohort study. Int J Drug Policy. 20 de abril de 2019;69:16-23.
• Schmidt LA, Jacobs LM, Vlahov D, Spetz J. Impacts of Medical Marijuana Laws on Young Americans Across the Developmental Spectrum. Matern Child Health J. abril de 2019;23(4):486-95.
• Tucker JS, Pedersen ER, Seelam R, Dunbar MS, Shih RA, D’Amico EJ. Types of cannabis and tobacco/nicotine co-use and associated outcomes in young adulthood. Psychol Addict Behav. junio de 2019;33(4):401-11.
• Wadsworth E, Hammond D. International differences in patterns of cannabis use among youth: Prevalence, perceptions of harm, and driving under the influence in Canada, England & United States. Addict Behav. marzo de 2019;90:171-5.
• Weinkle L, Domen CH, Shelton I, Sillau S, Nair K, Alvarez E. Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legal. Mult Scler Relat Disord. enero de 2019;27:383-90.

2018

• Borodovsky JT, Budney AJ. Cannabis regulatory science: risk-benefit considerations for mental disorders. Int Rev Psychiatry. 2018;30(3):183-202.
• Bruce D, Brady JP, Foster E, Shattell M. Preferences for Medical Marijuana over Prescription Medications Among Persons Living with Chronic Conditions: Alternative, Complementary, and Tapering Uses. J Altern Complement Med. febrero de 2018;24(2):146-53.
• Crocker CE, Tibbo PG. The interaction of gender and cannabis in early phase psychosis. Schizophr Res. 2018;194:18-25.
• Daniulaityte R, Zatreh MY, Lamy FR, Nahhas RW, Martins SS, Sheth A, et al. A Twitter-based survey on marijuana concentrate use. Drug Alcohol Depend. 01 de 2018;187:155-9.
• Del Balzo G, Gottardo R, Mengozzi S, Dorizzi RM, Bortolotti F, Appolonova S, et al. «Positive» urine testing for Cannabis is associated with increased risk of traffic crashes. J Pharm Biomed Anal. 20 de marzo de 2018;151:71-4.
• Dutra LM, Parish WJ, Gourdet CK, Wylie SA, Wiley JL. Medical cannabis legalization and state-level prevalence of serious mental illness in the National Survey on Drug Use and Health (NSDUH) 2008-2015. Int Rev Psychiatry. 2018;30(3):203-15 .
• Fitzcharles MA, Eisenberg E. Medical cannabis: A forward vision for the clinician. Eur J Pain. 2018;22(3):485-91.
• Halladay J, Petker T, Fein A, Munn C, MacKillop J. Brief interventions for cannabis use in emerging adults: protocol for a systematic review, meta-analysis, and evidence map. Syst Rev. 25 de 2018;7(1):106.
• Kalla A, Krishnamoorthy PM, Gopalakrishnan A, Figueredo VM. Cannabis use predicts risks of heart failure and cerebrovascular accidents: results from the National Inpatient Sample. J Cardiovasc Med (Hagerstown). septiembre de 2018;19(9):480-4.
• Kim J, de Castro A, Lendoiro E, Cruz-Landeira A, López-Rivadulla M, Concheiro M. Detection of in utero cannabis exposure by umbilical cord analysis. Drug Test Anal. abril de 2018;10(4):636-43.
• Krening C, Hanson K. Marijuana-Perinatal and Legal Issues With Use During Pregnancy. J Perinat Neonatal Nurs. marzo de 2018;32(1):43-52.
• Meacham MC, Paul MJ, Ramo DE. Understanding emerging forms of cannabis use through an online cannabis community: An analysis of relative post volume and subjective highness ratings. Drug Alcohol Depend. 01 de 2018;188:364-9.
• Meacham MC, Ramo DE, Kral AH, Riley ED. Associations between medical cannabis and other drug use among unstably housed women. Int J Drug Policy. 2018;52:45-51.
• Min JY, Min KB. Marijuana use is associated with hypersensitivity to multiple allergens in US adults. Drug Alcohol Depend. 01 de 2018;182:74-7.
• Naji L, Rosic T, Dennis B, Bhatt M, Sanger N, Hudson J, et al. The association between cannabis use and suicidal behavior in patients with psychiatric disorders: an analysis of sex differences. Biol Sex Differ. 11 de 2018;9(1):22.
• Rotermann M, Macdonald R. Analysis of trends in the prevalence of cannabis use in Canada, 1985 to 2015. Health Rep. 21 de febrero de 2018;29(2):10-20.
• Russell C, Rueda S, Room R, Tyndall M, Fischer B. Routes of administration for cannabis use - basic prevalence and related health outcomes: A scoping review and synthesis. Int J Drug Policy. 2018;52:87-96.
• Smart R, Osilla KC, Jonsson L, Paddock SM. Differences in alcohol cognitions, consumption, and consequences among first-time DUI offenders who co-use alcohol and marijuana. Drug Alcohol Depend. 01 de 2018;191:187-94.
• Sokoya M, Eagles J, Okland T, Coughlin D, Dauber H, Greenlee C, et al. Patterns of facial trauma before and after legalization of marijuana in Denver, Colorado: A joint study between two Denver hospitals. Am J Emerg Med. mayo de 2018;36(5):780-3.
• Steinemann S, Galanis D, Nguyen T, Biffl W. Motor vehicle crash fatalaties and undercompensated care associated with legalization of marijuana. J Trauma Acute Care Surg. 2018;85(3):566-71.
• Wadsworth E, Hammond D. Differences in patterns of cannabis use among youth: Prevalence, perceptions of harm and driving under the influence in the USA where non-medical cannabis markets have been established, proposed and prohibited. Drug and Alcohol Review. 2018;37(7):903-11.
• Xie M, Gupta MK, Archibald SD, Stanley Jackson B, Young JEM, Zhang H. Marijuana and head and neck cancer: an epidemiological review. J Otolaryngol Head Neck Surg. 22 de noviembre de 2018;47(1):73.

2017

• Akano OF. Marijuana Use and Self-reported Quality of Eyesight. Optom Vis Sci. 2017;94(5):630-3.
• Borodovsky JT, Lee DC, Crosier BS, Gabrielli JL, Sargent JD, Budney AJ. U.S. cannabis legalization and use of vaping and edible products among youth. Drug Alcohol Depend. 01 de 2017;177:299-306.
• Carliner H, Mauro PM, Brown QL, Shmulewitz D, Rahim-Juwel R, Sarvet AL, et al. The widening gender gap in marijuana use prevalence in the U.S. during a period of economic change, 2002-2014. Drug Alcohol Depend. 1 de enero de 2017;170:51-8.
• Cohn AM, Johnson AL, Rose SW, Rath JM, Villanti AC. Support for Marijuana Legalization and Predictors of Intentions to Use Marijuana More Often in Response to Legalization Among U.S. Young Adults. Subst Use Misuse. 28 de 2017;52(2):203-13.
• Cronce JM, Bittinger JN, Di Lodovico CM, Liu J. Independent Versus Co-occurring Substance Use in Relation to Gambling Outcomes in Older Adolescents and Young Adults. J Adolesc Health. mayo de 2017;60(5):528-33.
• Daniulaityte R, Lamy FR, Smith GA, Nahhas RW, Carlson RG, Thirunarayan K, et al. «Retweet to Pass the Blunt»: Analyzing Geographic and Content Features of Cannabis-Related Tweeting Across the United States. J Stud Alcohol Drugs. 2017;78(6):910-5.
• Gazibara T, Prpic M, Maric G, Pekmezovic T, Kisic-Tepavcevic D. Medical Cannabis in Serbia: The Survey of Knowledge and Attitudes in an Urban Adult Population. J Psychoactive Drugs. agosto de 2017;49(3):217-24.
• Guttmannova K, Kosterman R, White HR, Bailey JA, Lee JO, Epstein M, et al. The association between regular marijuana use and adult mental health outcomes. Drug Alcohol Depend. 01 de 2017;179:109-16.
• Hanna RC, Perez JM, Ghose S. Cannabis and development of dual diagnoses: A literature review. Am J Drug Alcohol Abuse. 2017;43(4):442-55.
• Hoffenberg EJ, Newman H, Collins C, Tarbell S, Leinwand K. Cannabis and Pediatric Inflammatory Bowel Disease: Change Blossoms a Mile High. J Pediatr Gastroenterol Nutr. 2017;64(2):265-71.
• Hunt PE, Miles J. The Impact of Legalizing and Regulating Weed: Issues with Study Design and Emerging Findings in the USA. Curr Top Behav Neurosci. 2017;34:173-98.
• Kerr DCR, Bae H, Phibbs S, Kern AC. Changes in undergraduates’ marijuana, heavy alcohol and cigarette use following legalization of recreational marijuana use in Oregon. Addiction. noviembre de 2017;112(11):1992-2001.
• Lake S, Kerr T, Capler R, Shoveller J, Montaner J, Milloy M-J. High-intensity cannabis use and HIV clinical outcomes among HIV-positive people who use illicit drugs in Vancouver, Canada. Int J Drug Policy. 2017;42:63-70.
• Livingston MD, Barnett TE, Delcher C, Wagenaar AC. Recreational Cannabis Legalization and Opioid-Related Deaths in Colorado, 2000-2015. Am J Public Health. 2017;107(11):1827-9.
• Mark K, Gryczynski J, Axenfeld E, Schwartz RP, Terplan M. Pregnant Women’s Current and Intended Cannabis Use in Relation to Their Views Toward Legalization and Knowledge of Potential Harm. J Addict Med. junio de 2017;11(3):211-6.
• Mattei TA. Proposition 64, Cannabis Legalization, and the California Secession Movement: Why Should Neurosurgeons Care? World Neurosurg. marzo de 2017;99:770-2.
• Mendiburo-Seguel A, Vargas S, Oyanedel JC, Torres F, Vergara E, Hough M. Attitudes towards drug policies in Latin America: Results from a Latin-American Survey. Int J Drug Policy. 2017;41:8-13.
• Pergam SA, Woodfield MC, Lee CM, Cheng G-S, Baker KK, Marquis SR, et al. Cannabis use among patients at a comprehensive cancer center in a state with legalized medicinal and recreational use. Cancer. 15 de noviembre de 2017;123(22):4488-97.
• Richards JR. Cannabinoid hyperemesis syndrome: A disorder of the HPA axis and sympathetic nervous system? Med Hypotheses. junio de 2017;103:90-5.
• Romanowski KS, Barsun A, Kwan P, Teo EH, Palmieri TL, Sen S, et al. Butane Hash Oil Burns: A 7-Year Perspective on a Growing Problem. J Burn Care Res. febrero de 2017;38(1):e165-71.
• Shariff JA, Ahluwalia KP, Papapanou PN. Relationship Between Frequent Recreational Cannabis (Marijuana and Hashish) Use and Periodontitis in Adults in the United States: National Health and Nutrition Examination Survey 2011 to 2012. J Periodontol. 2017;88(3):273-80.
• Sznitman SR. Do recreational cannabis users, unlicensed and licensed medical cannabis users form distinct groups? Int J Drug Policy. 2017;42:15-21.
• Treat L, Chapman KE, Colborn KL, Knupp KG. Duration of use of oral cannabis extract in a cohort of pediatric epilepsy patients. Epilepsia. 2017;58(1):123-7.
• Tuck A, Hamilton HA, Agic B, Ialomiteanu AR, Mann RE. Past year cannabis use and problematic cannabis use among adults by ethnicity in Ontario. Drug Alcohol Depend. 01 de 2017;179:93-9.
• Vincent PC, Collins RL, Liu L, Yu J, De Leo JA, Earleywine M. The effects of perceived quality on behavioral economic demand for marijuana: A web-based experiment. Drug Alcohol Depend. 1 de enero de 2017;170:174-80.
• Vujcic I, Pavlovic A, Dubljanin E, Maksimovic J, Nikolic A, Sipetic-Grujicic S. Attitudes Toward Medical Cannabis Legalization Among Serbian Medical Students. Subst Use Misuse. 29 de 2017;52(9):1225-31.
• Wang GS, Hall K, Vigil D, Banerji S, Monte A, VanDyke M. Marijuana and acute health care contacts in Colorado. Prev Med. noviembre de 2017;104:24-30.
• Wang GS. Pediatric Concerns Due to Expanded Cannabis Use: Unintended Consequences of Legalization. J Med Toxicol. 2017;13(1):99-105.
• Weiss SRB, Howlett KD, Baler RD. Building smart cannabis policy from the science up. Int J Drug Policy. 2017;42:39-49.
• Wolff V, Jouanjus E. Strokes are possible complications of cannabinoids use. Epilepsy Behav. 2017;70(Pt B):355-63.
• Yankey BA, Rothenberg R, Strasser S, Ramsey-White K, Okosun IS. Effect of marijuana use on cardiovascular and cerebrovascular mortality: A study using the National Health and Nutrition Examination Survey linked mortality file. Eur J Prev Cardiol. 2017;24(17):1833-40.

2016

• Wall MM, Mauro C, Hasin DS, Keyes KM, Cerdà M, Martins SS, et al. Prevalence of marijuana use does not differentially increase among youth after states pass medical marijuana laws: Commentary on and reanalysis of US National Survey on Drug Use in Households data 2002-2011. Int J Drug Policy. marzo de 2016;29:9-13.
• Albertson TE, Chenoweth JA, Colby DK, Sutter ME. The Changing Drug Culture: Medical and Recreational Marijuana. FP Essent. febrero de 2016;441:11-7.
• Alshaarawy O, Elbaz HA. Cannabis use and blood pressure levels: United States National Health and Nutrition Examination Survey, 2005-2012. J Hypertens. 2016;34(8):1507-12.
• Banwell E, Pavisian B, Lee L, Feinstein A. Attitudes to cannabis and patterns of use among Canadians with multiple sclerosis. Mult Scler Relat Disord. noviembre de 2016;10:123-6.
• Borodovsky JT, Crosier BS, Lee DC, Sargent JD, Budney AJ. Smoking, vaping, eating: Is legalization impacting the way people use cannabis? Int J Drug Policy. 2016;36:141-7.
• Guttmannova K, Lee CM, Kilmer JR, Fleming CB, Rhew IC, Kosterman R, et al. Impacts of Changing Marijuana Policies on Alcohol Use in the United States. Alcohol Clin Exp Res. enero de 2016;40(1):33-46.
• Hall W, Lynskey M. Evaluating the public health impacts of legalizing recreational cannabis use in the United States. Addiction. 2016;111(10):1764-73.
• Holmes LM, Popova L, Ling PM. State of transition: Marijuana use among young adults in the San Francisco Bay Area. Prev Med. 2016;90:11-6.
• Kalant H. A critique of cannabis legalization proposals in Canada. Int J Drug Policy. 2016;34:5-10.
• Kosterman R, Bailey JA, Guttmannova K, Jones TM, Eisenberg N, Hill KG, et al. Marijuana Legalization and Parents’ Attitudes, Use, and Parenting in Washington State. J Adolesc Health. 2016;59(4):450-6.
• Maxwell JC, Mendelson B. What Do We Know Now About the Impact of the Laws Related to Marijuana? J Addict Med. febrero de 2016;10(1):3-12.
• Pacula RL, Jacobson M, Maksabedian EJ. In the weeds: a baseline view of cannabis use among legalizing states and their neighbours. Addiction. 2016;111(6):973-80.
• Rechthand MM, Bashirelahi N. What every dentist needs to know about cannabis. Gen Dent. febrero de 2016;64(1):40-3.
• Sidney S. Marijuana Use and Type 2 Diabetes Mellitus: a Review. Curr Diab Rep. 2016;16(11):117.
• Sobesky M, Gorgens K. Cannabis and adolescents: Exploring the substance misuse treatment provider experience in a climate of legalization. Int J Drug Policy. 2016;33:66-74.
• Thomasius R, Holtmann M. [Are protection of minors and cannabis legalization compatible with each other? – The legalization debate from a child and adolescent psychiatric point of view]. Z Kinder Jugendpsychiatr Psychother. 2016;44(2):95-100.
• Wang JB, Ramo DE, Lisha NE, Cataldo JK. Medical marijuana legalization and cigarette and marijuana co-use in adolescents and adults. Drug Alcohol Depend. 1 de septiembre de 2016;166:32-8.
• Wilkinson ST, Yarnell S, Radhakrishnan R, Ball SA, D’Souza DC. Marijuana Legalization: Impact on Physicians and Public Health. Annu Rev Med. 2016;67:453-66.
• Williams J, van Ours JC, Grossman M. Attitudes to legalizing cannabis use. Health Econ. 2016;25(9):1201-16.

2015

• Ammerman S, Ryan S, Adelman WP, Committee on Substance Abuse, the Committee on Adolescence. The impact of marijuana policies on youth: clinical, research, and legal update. Pediatrics. marzo de 2015;135(3):e769-785.
• Biehl JR, Burnham EL. Cannabis Smoking in 2015: A Concern for Lung Health? Chest. septiembre de 2015;148(3):596-606.
• Committee on Substance Abuse, Committee on Adolescence, Committee on Substance Abuse Committee on Adolescence. The impact of marijuana policies on youth: clinical, research, and legal update. Pediatrics. marzo de 2015;135(3):584-7.
• Daniulaityte R, Nahhas RW, Wijeratne S, Carlson RG, Lamy FR, Martins SS, et al. «Time for dabs»: Analyzing Twitter data on marijuana concentrates across the U.S. Drug Alcohol Depend. 1 de octubre de 2015;155:307-11.
• Deogan C, Zarabi N, Stenström N, Högberg P, Skärstrand E, Manrique-Garcia E, et al. Cost-Effectiveness of School-Based Prevention of Cannabis Use. Appl Health Econ Health Policy. octubre de 2015;13(5):525-42.
• Gartner CE. Mull it over: cannabis vaporizers and harm reduction. Addiction. noviembre de 2015;110(11):1709-10.
• Hall W, Weier M. Assessing the public health impacts of legalizing recreational cannabis use in the USA. Clin Pharmacol Ther. junio de 2015;97(6):607-15.
• Hefner K, Sofuoglu M, Rosenheck R. Concomitant cannabis abuse/dependence in patients treated with opioids for non-cancer pain. Am J Addict. septiembre de 2015;24(6):538-45.
• Jehle CC, Nazir N, Bhavsar D. The rapidly increasing trend of cannabis use in burn injury. J Burn Care Res. febrero de 2015;36(1):e12-17.
• Mashhoon Y, Sava S, Sneider JT, Nickerson LD, Silveri MM. Cortical thinness and volume differences associated with marijuana abuse in emerging adults. Drug Alcohol Depend. 1 de octubre de 2015;155:275-83.
• Metz TD, Stickrath EH. Marijuana use in pregnancy and lactation: a review of the evidence. Am J Obstet Gynecol. diciembre de 2015;213(6):761-78.
• Ogrodnik M, Kopp P, Bongaerts X, Tecco JM. An economic analysis of different cannabis decriminalization scenarios. Psychiatr Danub. septiembre de 2015;27 Suppl 1:S309-314.
• Pacek LR, Mauro PM, Martins SS. Perceived risk of regular cannabis use in the United States from 2002 to 2012: differences by sex, age, and race/ethnicity. Drug Alcohol Depend. 1 de abril de 2015;149:232-44.
• Rehm J, Fischer B. Cannabis legalization with strict regulation, the overall superior policy option for public health. Clin Pharmacol Ther. junio de 2015;97(6):541-4.
• Roth CK, Satran LA, Smith SM. Marijuana Use in Pregnancy. Nurs Womens Health. noviembre de 2015;19(5):431-7.
• Schauer GL, Berg CJ, Kegler MC, Donovan DM, Windle M. Assessing the overlap between tobacco and marijuana: Trends in patterns of co-use of tobacco and marijuana in adults from 2003-2012. Addict Behav. octubre de 2015;49:26-32.

2014

• Choo EK, Benz M, Zaller N, Warren O, Rising KL, McConnell KJ. The impact of state medical marijuana legislation on adolescent marijuana use. J Adolesc Health. agosto de 2014;55(2):160-6.
• Couper FJ, Peterson BL. The prevalence of marijuana in suspected impaired driving cases in Washington state. J Anal Toxicol. octubre de 2014;38(8):569-74.
• Power RA, Verweij KJH, Zuhair M, Montgomery GW, Henders AK, Heath AC, et al. Genetic predisposition to schizophrenia associated with increased use of cannabis. Mol Psychiatry. noviembre de 2014;19(11):1201-4.